The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
N | Nervous system | |
2
|
N05 | Psycholeptics | |
3
|
N05A | Antipsychotics | |
4
|
N05AF | Thioxanthene derivatives |
| Code | Title | |
|---|---|---|
| N05AF01 | Flupentixol | |
| N05AF02 | Clopenthixol | |
| N05AF03 | Chlorprothixene | |
| N05AF04 | Tiotixene | |
| N05AF05 | Zuclopenthixol |
| Active Ingredient |
|---|
|
|
|
|
|
|
|
|
|
Zuclopenthixol is a potent neuroleptic of the thioxanthene series with a piperazine side-chain. The antipsychotic effect of neuroleptics is related to their dopamine receptor blocking effect. |
| Document | Type | Information Source | |
|---|---|---|---|
| CLOPIXOL ACUPHASE Solution for injection | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| CLOPIXOL Film-coated tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| CLOPIXOL Solution for injection | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| DEPIXOL Film-coated tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| DEPIXOL Solution for injection | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| FLUANXOL / FLUANXOL DEPOT Tablet, Solution for injection | MPI, CA: SPM | Health Products and Food Branch (CA) | |
| FLUANXOL Film-coated tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |